Article
Transcutaneous immunization with cytotoxic T-cell peptide epitopes provides effective antitumor immunity in mice.
Journal of immunotherapy (Hagerstown, Md. : 1997) - 1 Jan 2000
Itoh Tsuyoshi, Celis Esteban
Abstract excerpt
Much attention has been focused on transcutaneous immunization strategies to stimulate systemic cytotoxic T lymphocyte responses leading to anti-tumor or anti-microbial immunity. Here we report that topical application of vaccines consisting of synthetic peptides formulated with imiquimod, a Toll-like receptor agonist that functions as a potent adjuvant generates strong T cell responses that exhibit effective...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
